Diabetes Health Type 1 & 2 : Lilly and Dexcom Collaborate on New Program for HCPs to Increase Visibility for Benefits of Mealtime Insulin and G6 CGMs
Nadia Al-Samarrie I recently interviewed Dan Pollom, senior medical advisor at Lilly, about Lyumjev – a fast-acting insulin approved in
Read more